VLDLR Antikörper (AA 551-650)
(1 reference)-
- Target Alle VLDLR Antikörper anzeigen
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
-
Bindungsspezifität
- AA 551-650
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VLDLR Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human VLDL Receptor
- Isotyp
- IgG
- Top Product
- Discover our top product VLDLR Primärantikörper
-
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 484-510) antibody
VLDLR Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB21297 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 418-722) antibodyVLDLR Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 133-247) antibodyVLDLR Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) antibodyVLDLR Reaktivität: Human, Ratte, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (C-Term) antibodyVLDLR Reaktivität: Human, Ratte IHC, ISt, StM Wirt: Maus Monoclonal VLDLR-1337 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) antibodyVLDLR Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 1H10 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 608-642) antibodyVLDLR Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53886 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (C-Term) antibodyVLDLR Reaktivität: Human, Ratte ELISA, Coat Wirt: Kaninchen Monoclonal VLDLR-2896R unconjugated Recombinant Antibody
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
FCM 1:20-100 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
: "The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4497-509, (2014) (PubMed).
-
: "The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 192, Issue 10, pp. 4497-509, (2014) (PubMed).
-
- Target
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
- Andere Bezeichnung
- VLDL Receptor (VLDLR Produkte)
- Synonyme
- CARMQ1 antikoerper, CHRMQ1 antikoerper, VLDLRCH antikoerper, AA408956 antikoerper, AI451093 antikoerper, AW047288 antikoerper, vldlr antikoerper, very low density lipoprotein receptor antikoerper, very low density lipoprotein receptor S homeolog antikoerper, VLDLR antikoerper, Vldlr antikoerper, vldlr.S antikoerper
- Hintergrund
-
Synonyms: CARMQ1, CHRMQ1, VLDLRCH, Very low-density lipoprotein receptor, VLDL receptor, VLDL-R, VLDLR
Background: Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity).
- Gen-ID
- 7436
- UniProt
- P98155
- Pathways
- Cellular Response to Molecule of Bacterial Origin
-
